The DOI matches its OpenAlex record.
Pneumococcal bacteremia in Charleston County, South Carolina. A decade later
Abstract
Since nationwide surveillance for pneumococcal bacteremia in the United States is not done, community-based studies are useful alternative methods to monitor trends in this disease. Data on the incidence of pneumococcal bacteremia in Charleston County, South Carolina, from 1974 to 1976, have been used to support cost-effective pneumococcal vaccine programs for the elderly. We reevaluated the incidence of pneumococcal bacteremia in Charleston County in 1986 and 1987 to assess whether earlier estimates remained valid given changes in medical practice. During 1986 and 1987, overall annual incidence of pneumococcal bacteremia in Charleston County was 18.7 per 100,000 (95% confidence limits, 13.7 to 23.6 per 100,000), which represents a 2.3-fold increase over the earlier rate. The increase coincided with a 2.2-fold increase in the annual number of blood cultures processed at four Charleston County hospital laboratories from 1975 to 1987 despite only a 1.1-fold increase in the number of patients discharged from these hospitals. Annualized rates increased 2.3-fold for adults more than or equal to 65 years old to 53 per 100,000 and 4.6-fold for children less than 2 years old to 162 per 100,000. The case-fatality rate of bacteremic patients was 18%, compared with 21% in the earlier study. The case-fatality rate for adults more than or equal to 65 years of age was 44%. Ninety-one percent of adults 19 to 64 years old with bacteremia had underlying medical conditions for which pneumococcal vaccine is recommended; all persons 55 to 64 years old had at least one underlying condition. The marked increases in pneumococcal bacteremia rates detected are likely due to more routine culturing of blood from symptomatic patients with pneumococcal disease. These findings emphasize the need for effective programs promoting use of pneumococcal vaccine in high-risk groups, particularly those more than or equal to 65 years old, and the development of a more immunogenic vaccine for children less than 2 years old.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Practice Guidelines for the Management of Community-Acquired Pneumonia in Adults
Bartlett, J. G., Dowell, S. F., Mandell, L. A., File, T. M., Musher, D. M., & Fine, M. J. (2000) · Clinical Infectious Diseases · doi:10.1086/313954 · Cited by 2,286
Access to effective antimicrobials: a worldwide challenge
Laxminarayan, R., Matsoso, P., Pant, S., Brower, C., Røttingen, J.-A., Klugman, K., & Davies, S. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00474-2 · Cited by 1,465
Weinstein, M. P., Towns, M. L., Quartey, S. M., Mirrett, S., Reimer, L. G., Parmigiani, G., & Barth Reller, L. (1997) · Clinical Infectious Diseases · doi:10.1093/clind/24.4.584 · Cited by 1,228
Marston, B. J. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360129015 · Cited by 909
A meta-analysis of randomized controlled trials: Efficacy of selenium treatment for sepsis
Li, S., Tang, T., Guo, P., Zou, Q., Ao, X., Hu, L., & Tan, L. (2019) · Medicine · doi:10.1097/md.0000000000014733 · Cited by 802
Cigarette Smoking and Invasive Pneumococcal Disease
Nuorti, J. P., Butler, J. C., Farley, M. M., Harrison, L. H., McGeer, A., Kolczak, M. S., & Breiman, R. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003093421002 · Cited by 798
Self-citationRecognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection
Malley, R., Henneke, P., Morse, S. C., Cieslewicz, M. J., Lipsitch, M., Thompson, C. M., Kurt-Jones, E., Paton, J. C., Wessels, M. R., & Golenbock, D. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0435928100 · Cited by 704
Emergence of Drug-Resistant Pneumococcal Infections in the United States
Breiman, R. F. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510470035031 · Cited by 562
Self-citationMusher, D. M. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.4.801 · Cited by 519
Efficacy of Pneumococcal Vaccination in Adults: A Meta-analysis of Randomized Controlled Trials
Fine, M. J. (1994) · Archives of Internal Medicine · doi:10.1001/archinte.1994.00420230051007 · Cited by 370
Cost-effectiveness of Vaccination Against Pneumococcal Bacteremia Among Elderly People
Sisk, J. E. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03550160053038 · Cited by 362
The Influence of Chronic Illnesses on the Incidence of Invasive Pneumococcal Disease in Adults
Kyaw, M. H., Rose, Jr., Fry, A. M., Singleton, J. A., Moore, Z., Zell, E. R., Whitney, C. G., & Active Bacterial Core Surveillance Program of the Emerging Infections Program Network (2005) · The Journal of Infectious Diseases · doi:10.1086/431521 · Cited by 328
Pneumococcal Disease during HIV Infection: Epidemiologic, Clinical, and Immunologic Perspectives
Janoff, E. N., Breiman, R. F., Daley, C. L., & Hopewell, P. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-314 · Cited by 323
Self-citationPopulation-Based Epidemiology and Microbiology of Community-Onset Bloodstream Infections
Laupland, K. B., & Church, D. L. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00002-14 · Cited by 323
Kim, P. E., Musher, D. M., Glezen, W. P., Barradas, M. C. R., Nahm, W. K., & Wright, C. E. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.1.100 · Cited by 285
Nuorti, J. P., Butler, J. C., Crutcher, J. M., Guevara, R., Welch, D., Holder, P., & Elliott, J. A. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382601 · Cited by 270
Antibiotic Resistance in Streptococcus pneumoniae
Tomasz, A. (1997) · Clinical Infectious Diseases · doi:10.1093/clinids/24.supplement_1.s85 · Cited by 264
Bacteremia With Streptococcus pneumoniae: Implications for Therapy and Prevention
Plouffe, J. F. (1996) · JAMA · doi:10.1001/jama.1996.03530270034028 · Cited by 252
Metadata
- Authors
- Breiman, R. F.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1990-07-01
- Volume
- 150
- Issue
- 7
- Pages
- 1401-1405
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W4254197508
- Cited by
- 216
- References
- 0
- FWCI
- 6.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.